Back to search

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

Data up to Jan 2025

Published2020
Citations1,174
References20

Total Citations Per Year

Abstract

References (20)

Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle

2020 • 3,510 citations

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

2020 • 1,743 citations

Coronaviruses — drug discovery and therapeutic options

2016 • 1,703 citations

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings

2004 • 1,684 citations

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

2018 • 1,447 citations

Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection

2017 • 889 citations

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

2020 • 619 citations

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

2019 • 462 citations

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion

2016 • 267 citations

Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial

2018 • 257 citations

Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor

2016 • 242 citations

The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function

2017 • 223 citations

Influenza virus-related critical illness: prevention, diagnosis, treatment

2019 • 177 citations

Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection

2019 • 144 citations

Natural Products as Potential Leads Against Coronaviruses: Could They be Encouraging Structural Models Against SARS-CoV-2?

2020 • 119 citations

Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach

2020 • 73 citations

Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease

2019 • 58 citations

Focus on the 2019 Novel Coronavirus (SARS-CoV-2)

2020 • 51 citations

An overview on COVID-19: reality and expectation

2020 • 47 citations

Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016

2018 • 34 citations

Cited By (0)

Loading...
Drug treatment options for the 2019-new coronavirus (2019-nCoV) (2020) – BioScience Trends | Metascience Observatory Explorer